Molecular machinery underlying tissue-specific development of adverse drug reactions induced by anticancer drugs
| Project/Area Number |
22590143
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Medical pharmacy
|
|---|
| Research Institution | Showa University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2010 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2012: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2011: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2010: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Keywords | 臨床薬学 / 化学療法 / 副作用発現機構 / 5-フルオロウラシル / p53 / 骨髄毒性 / 医薬品副作用 / 酸化ストレス / Nrf2 |
|---|
| Research Abstract |
The purpose of this study was to clarify whether 5-fluorouracil (5-FU)-induced myelotoxicity is a cause of oxidative stress and to demonstrate machineryinvolved in tissue-specific development of adverse-drug reactions. 5-FU-inducedmyelotoxicity in mice was directly linked to intracellular glutathione and activity of Nrf2,indicating that oxidative stress is involved in the process. In addition, 5-FU induced different responses of p53 in the bone marrow and tumor xenografts, which could be participated in the tissue selectivity of the 5-FU-mediated toxicity.
|
Report
(4 results)
Research Products
(53 results)
